Injectsense adds experts to Medical advisory board
Injectsense, Inc. an innovative medical device firm that develops sensor-enabled digital health systems to measure therapy effectiveness, announced today additional members of its medical advisory board. The board, which includes world renowned specialists and surgeons in the ophthalmic field, provides valuable feedback on device requirements, procedures, risk mitigation, and regulatory issues. Ophthalmology is the company`s initial market.
New members of the medical advisory board include Richard Lindstrom, M.D., founding member and attending surgeon at Minnesota Eye Consultants; and Kuldev Singh, M.D., Professor of Ophthalmology and Director of the Glaucoma Service at Stanford University, who serves on the FDA Advisory Committee for Ophthalmic Devices. Other members of the medical advisory board include Dr. Myron Yanoff, M.D., author or co-author of 30 textbooks on ophthalmology including the standard textbook Ophthalmology; Dr. Arthur Sit, Associate Professor and Vice Chair of Ophthalmology at the Mayo Clinic; Dr. Iqbal "Ike" Ahmed, M.D., who developed the field of micro-invasive glaucoma surgery (MIGS); Dr. Ernesto Collazo, a leader in laser eye surgery and advanced technology in healthcare; Dr. Jason Bacharach, founder and director of research at North Bay Eye Associates, specializing in pharmaceutical and device studies; Dr. Stephen Sinclair, owner and director of Sinclair Retinal Associates and adjunct professor at the Drexel University School of Medicine; and Dr. William Daney, a clinical emergency medicine specialist, medical director and instructor, with a focus on cardiology.
"We are extremely fortunate to have secured the commitment and ongoing strategic feedback from highly recognized medical professionals who understand the urgent need for continuous monitoring and clinically actionable information," said Ariel Cao, CEO and president, Injectsense, Inc. "This continuous data, when filtered, will enable earlier treatment for progressive disease."